These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9402751)

  • 1. [Paclitaxel (Taxol) opens new perspectives on bronchial carcinoma. 8th World Conference on Lung Cancer. Dublin, 10-15 August 1997].
    Pneumologie; 1997 Oct; 51(10 Suppl):1-6. PubMed ID: 9402751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Taxol and simultaneous radiotherapy in stage IIIA and IIIB, locally advanced, non-small-cell bronchial carcinoma. Phase-I clinical trial].
    Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Kettner H; Kober B; Zamboglou N
    Strahlenther Onkol; 1996 May; 172 Suppl 1():9-15. PubMed ID: 8633271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bronchial carcinoma: Paclitaxel combinations are administered at an ever earlier stage of the disease. 34th Annual Meeting of the American Society of Clinical Oncology (ASCO). Los Angeles, 16-19 May 1998].
    Pneumologie; 1998 Aug; 52(8 Suppl Bronchialk):1-8. PubMed ID: 9750451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Options in the therapy of bronchial carcinoma: new perspectives through multimodal concepts with Paclitaxel].
    Internist (Berl); 1997 Oct; 38(10 Suppl Neue):1-4. PubMed ID: 9373389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Paclitaxel and new concepts. Advances in the management of bronchial carcinoma].
    Internist (Berl); 1999 Jun; 40(6 Suppl):1-8. PubMed ID: 10399088
    [No Abstract]   [Full Text] [Related]  

  • 7. [New Perspectives on the Management of Lung Cancer with Paclitaxel. Forum report. Barcelona, 14 March].
    Campisi C; Zappalà A; Terenzi S
    Tumori; 1998; 84(4):A1-9. PubMed ID: 9867669
    [No Abstract]   [Full Text] [Related]  

  • 8. [New perspectives in the treatment of bronchial cancer. Pan-European Lung Cancer Forum: "New perspectives on the Management of Lung Cancer". Sitges/Barcelona, 14 March 1998].
    Pneumologie; 1998 May; 52(5 Suppl Neue Persp):1-8. PubMed ID: 9648496
    [No Abstract]   [Full Text] [Related]  

  • 9. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 1: Lung Cancer. Puerto Rico, March 12-16, 1997.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-162; quiz S12-163-S12-173. PubMed ID: 9340788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
    Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-agent paclitaxel in the treatment of small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):16-7. PubMed ID: 9007115
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma].
    Wolf M; Faoro C; Görg C; Merte H; Pfab R; Diergarten K; Havemann K
    Strahlenther Onkol; 1996 May; 172 Suppl 1():5-8. PubMed ID: 8633270
    [No Abstract]   [Full Text] [Related]  

  • 13. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. St. Thomas, U.S.Virgin Islands, March 25-29, 1998. Proceedings and abstracts.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-155. PubMed ID: 10206912
    [No Abstract]   [Full Text] [Related]  

  • 14. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
    Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
    J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Navelbine (Vinorelbin)--current trends and results. Satellite Symposium on occasion of the 22nd German Cancer Congress. Berlin, 20 February 1996].
    Pneumologie; 1996 Apr; 50(4 Suppl):1-4. PubMed ID: 9022415
    [No Abstract]   [Full Text] [Related]  

  • 17. [Facts and perspectives in the therapy of cancers of the breast, ovary and bronchi].
    Internist (Berl); 1999 Aug; 40(8 Suppl Fakten):1-8. PubMed ID: 10511868
    [No Abstract]   [Full Text] [Related]  

  • 18. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Kris MG; Millward M
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
    [No Abstract]   [Full Text] [Related]  

  • 19. Docetaxel as second-line chemotherapy for non-small-cell lung cancer.
    Roila F; Del Favero A; Ballatori E
    J Clin Oncol; 2000 Nov; 18(21):3738-9. PubMed ID: 11054450
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term results of CHART and weekly Paclitaxel in locally advanced non-small cell lung cancer.
    Oral EN
    Lung Cancer; 2005 Sep; 49(3):421-2. PubMed ID: 16102609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.